Blog

The James Group Newsletter Vol. 5, Num. 14: Blue House, Red Senate, HC Top Issue for Voters, Cheap Health Plans Not Built for All, Montana & Medicaid, Medicare Expands to In-Home Supp, ID NE & UT Vote for Medicaid Expansion, Abortion Rights, HHS Opt Out of BC Mandate, IV Painkiller Alternative, Future of CVS, Possible Universal Flu Vaccine

The James Group Newsletter Vol. 5, Num. 13: Drug Spending vs. Medicaid, Rising HC Bills, If Docs Got Paid Only Medicare Rates, Broad Spending Bill, Easing Costs on Drug Comps, Protect Against Surprise Med Bills, Life Insurance Incentives, Merger Cleared..

The James Group Newsletter Vol. 5, Num. 8: Hosp Contrib to High HC Prices, Lifetime limits on Medicaid, $15b Spending Cuts, Drug Plans Drop, MD Insurers Seek Prem Hikes 2019, Walmart Opioid Restrictions, E.Coli, Expand Veteran HC, CVS/Aetna Deal, Price: ObamaCare Indiv Mandate

The James Group Newsletter Vol. 5, Num. 12: Pre-Ex Take Center Stage, Drug Cost Effects, Uninsured Rates Steady, Non-opioid pain meds, CA Gov Candidate Backs Universal HC, McCain's HC Legacy, Cigna-Express Scripts Approved, Senate Backs $854B Bill, MD

The James Group Newsletter Vol. 5, Num. 7: ACA Insurance Rewritten, CA Aims to Tackle HC Prices, Ryan Leaves Congress, Opioid Crisis, ACA Standing, FDA Restrictions, CVS Improperly Reporting, UHG Forms Army, Boehler As Director, Reinsurance Pools, MegaMerger

The James Group Newsletter Vol. 5, Num. 11: Paring Down Drug Prices, Medicare Overhaul ACOs, Urgent HC Need, RA Merger Cancellation, Opioid Prescribing Reduced, HHS & Drug Companies, AMA Opposes CVS/Aetna Merger, Genetic Testing, ACA Plan Premium Increases, Future Risk Corridor Payments, ACA Subsidies, Cigna Overpaying Express Scripts

The James Group Newsletter Vol. 5, Num. 6: Health Premiums Loom, Fed Money for Opioid Crisis, Wellness Tips, $1.3 Trillion Budget, The Omnibus Bill, GOP ObamaCare Fix, KY Abortion Restrictions, TX Medicaid

 

The james Group Newsletter Vol. 5, Num. 10: Association Health Plan, Merck to Lower Drug Prices, KY Resotring Medicaid Benefits, ACA Risk Adjustment Payments, Drug Imports to Counter Price Hikes, UnitedHealth Post Big Profit Jump, CA Rates to Rise 8.7% Next Year, EMR Enhancement of Approved Drugs, Bill Advanced to Halt Employer Mandate, OK Medicaid Approved for Drug Pricing Experiment

The James Group Newsletter Vol. 5, Num. 5: Budget Bill, Penalties for Drug Dealers, Opioid Production Quota, Gun Control, Panel to Review Opioid Crisis, KY Votes to Tax Opioids, ObamaCare at All-Time High, VA Rally Medicaid Growth, Uber/Lyft Ride Share, 2018 Index Figures Changed, VSP $40 Coupon

Vol. 5, Num. 9: Drugmakers costing US $$, 'Right to Try' Bill Approved, Restrictions on Abortion Funding, Gene Therapies, $7M to Fight Ebola Outbreak, VT Passes Drug Import Law, Fix VA Med Records, FDA Approves Migraine Medicine

Connect

Icon FacebookIcon TwitterIcon Mail

Location

Memphis Office
The James Group, LLC
6750 Poplar Avenue
Suite 208
Memphis, TN 38138
Phone: (901) 273-8600
Fax: (901) 273-8700
Atlanta Office
The James Group, LLC 
1100 Circle 75 Parkway SE, Suite 1500
Atlanta, GA 30339
Phone: 770-709-7210
Fax: 901-273-8700
Logo Footer © The James Group. All Rights Reserved.